We further compared the expression of immune checkpoints, which are molecules expressed on immune cells that inhibit immune cell function, leading to ineffective anti-tumor immune responses and tumor immune evasion, between ER+ and ER− BC. This evidence concerns the gene ESR1 and breast cancer.